• Artemis Health Raises $8.3 Million Series A Round to Expand Benefits Optimization Platform

    May 10, 2017, 12:32 PM by Michael Croft
    SALT LAKE CITY, UT - May 10, 2017 - Artemis Health Raises $8.3 Million Series A Round to Expand Benefits Optimization Platform Platform Now Covers Over One Million Lives Across Several Dozen Large Employers Artemis Health, a health data analytics company, raised $8
    Full story

  • Hacking Bio-IT: Bio-IT World Launches First Hackathon

    May 10, 2017, 09:10 AM by Michael Croft

    Bio-IT World | At the end of May, the Bio-IT World Conference & Expo will host its first Bio-IT Hackathon, this year focusing on FAIR data, data that are findable, accessible, interoperable, and reusable.

    Full story

  • ZEISS Crossbeam 550 sets new standards in 3D analytics and sample preparation with FIB-SEMs

    May 9, 2017, 10:56 AM by Michael Croft
    JENA, GERMANY - May 9, 2017 - ZEISS presents a new generation of focused ion beam scanning electron microscopes (FIB-SEMs) for high-end applications in research and industry
    Full story

  • Sekisui XenoTech Awarded Cryopreservation Patent

    May 9, 2017, 10:05 AM by Michael Croft
    KANSAS CITY, KS, UNITED STATES - May 9, 2017 - Sekisui XenoTech was issued U.S. Patent No. 9,642,355 for the “cryopreservation of cells and subcellular fractions,” specifically related to Sekisui XenoTech’s CryostaX® test systems, which are the only single-freeze pooled hepatocyte products in the industry
    Full story

  • Edico Announces $22M Round

    May 9, 2017, 09:35 AM by Michael Croft
    Bio-IT World News Brief | Edico Genome announced today it has raised $22 million in a Series B financing to expand market adoption and product development of its DRAGEN platform. New investor Dell Technologies Capital, the venture arm of Dell Technologies, led the round and all existing investors participated, including Qualcomm Ventures, Axon Ventures and life sciences industry executive Greg Lucier.
    Full story

  • Optibrium and Goldfinch Bio Sign Agreement for StarDrop License

    May 9, 2017, 07:50 AM by Michael Croft
    CAMBRIDGE, UK - May 9, 2017 - Optibrium, a developer of software for small molecule discovery, and Goldfinch Bio, a company focused on discovering and developing precision therapies to treat patients with kidney disease, today announced that the company has signed a multi-year agreement to license Optibrium’s StarDrop software
    Full story

  • KCR Expands Its Presence in the U.S. Market

    May 9, 2017, 06:22 AM by Michael Croft
    BERLIN, GERMANY - May 9, 2017 - KCR, a full service contract research organization, has announced today that it will be moving to a new office in Boston, MA, United States
    Full story

  • BC Platforms Closes USD $10 million Series B Financing to accelerate knowledge platform development

    May 9, 2017, 02:02 AM by Michael Croft
    BASEL, SWITZERLAND - May 9, 2017 - BC Platforms, a world leader in genomic data management solutions, today announces that it has closed a $USD 10 million financing round
    Full story

  • PacBio's Juliet Minor Variant Software

    May 8, 2017, 12:15 PM by Michael Croft
    Bio-IT World At PacBio’s SMRT scientific symposium and developers meeting last week held at the Leiden University Medical Center in the Netherlands, Lance Hepler, with PacBio, announced three apps coming in the next SMRT Analysis release: minor variants, structural variation, and multiplexed microbe WGS.
    Full story

  • NIH Grant Limits Rile Biomedical Research Community

    May 5, 2017, 12:52 PM by Michael Croft
    Nature News & Comment | Scientists are split over whether limiting grant support to individuals will help young researchers or hurt collaboration.
    Full story

  • Precision NanoSystems @ CLINAM 2017

    May 5, 2017, 04:32 AM by Michael Croft
    VANCOUVER, BC, CANADA - May 5, 2017 - Precision NanoSystems will be showcasing the benefits of its NanoAssemblr™ System and microfluidics technologies on booth #6 at this year's European Foundation of Clinical Nanomedicine (CLINAM) conference and exhibition
    Full story

  • 2017 Bio-IT World Best Of Show People's Choice Award Contenders

    May 4, 2017, 12:05 PM by Michael Croft

    Bio-IT World | Bio-IT World has announced the 2017 Best of Show competition with the Bio-IT World People’s Choice award. The four awards named by the judges and the People’s Choice Award will be announced at a live event on the Bio-IT World Expo floor at 5:30 pm on Wednesday, May 24.

    Full story

  • TraceLink Reports Highest Quarterly Revenue and Record-Breaking Growth in EMEA New Sales Bookings for Q1 2017

    May 4, 2017, 09:46 AM by Michael Croft
    NORTH READING, MA - May 4, 2017 - North Reading, MA (May 4, 2017)-TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced financial and company results for the first quarter of 2017
    Full story

  • RowAnalytics launches public beta of spot.my, its new deep semantic search tool for life science research

    May 4, 2017, 09:30 AM by Michael Croft
    OXFORD, UNITED KINGDOM - May 4, 2017 - Complex data analytics software provider RowAnalytics Ltd today announced the beta release of spot.my, its powerful new search platform for open access life science literature
    Full story

  • Apply AI to De-Risk Drug Discovery & Development

    May 4, 2017, 07:12 AM by Michael Croft
    BOSTON, MA - May 8, 2017 - Unsustainable - The one word frequently used to describe traditional R&D. However, AI technologies are going to change that
    Full story

  • GenSight Biologics Appoints Mohamed Genead as Chief Medical Officer

    May 3, 2017, 12:22 PM by Michael Croft
    PARIS, FRANCE - May 3, 2017 - GenSight Biologics S.A. (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company that discovers and develops innovative gene therapies for neurodegenerative retinal diseases and diseases of the central nervous system, announced it has appointed Mohamed Genead, M
    Full story

  • Anniversary Agenda: A Preview of #BioIT17

    May 3, 2017, 11:20 AM by Michael Croft

    Bio-IT World At the end of this month, Bio-IT World celebrates a milestone: the 15th anniversary of the Bio-IT World Conference & Expo. Fifteen years after we launched the event, it has grown into a community that we are proud of, a community of clever, innovative people working from all sides on the problems affecting life sciences. But we’re excited about more than just a champagne toast at this year’s celebration. Our 15th anniversary program in Boston, May 23-25, might be the best yet.

    Full story

  • Heymann and Bhowmik Launch Converge Boston’s Latest Venture Firm

    May 3, 2017, 09:48 AM by Michael Croft
    Xconomy | Boston's tech investing landscape has changed a lot in the past couple of years, with a wave of new early-stage funds popping up. That activity continued this week with the unveiling of Converge.
    Full story

  • Science Wins Reprieve In US Budget Deal

    May 2, 2017, 10:08 AM by Michael Croft
    Nature News & Comment | Congress gives National Institutes of Health a big boost and avoids cuts to research agencies sought by Trump.
    Full story

  • MDI Biological Laboratory Scientist Receives Grant to Study Peripheral Neuropathy

    Apr 28, 2017, 16:38 PM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Apr 28, 2017 - The MDI Biological Laboratory has announced that Sandra Rieger, Ph.D., has been awarded a highly competitive grant from the National Cancer Institute, an institute of the National Institutes of Health (NIH), to study the molecular mechanisms underlying chemotherapy-induced peripheral neuropathy, a side effect of cancer chemotherapy causing symptoms such as pain, tingling, temperature sensitivity and numbness in the extremities
    Full story